ROLE OF GLP-1 AGONISTS IN THE TREATMENT OF OBESITY-RELATED GASTROINTESTINAL DISORDERS. RMSR. 2025;3(4):1205-1214. Accessed October 12, 2026. https://medicalsciencereview.com/index.php/Journal/article/view/1966